Use of antiepileptic drugs in pregnancy

References

• Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia34, 453–468 (1993).
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Early identification of refractory epilepsy. N. Eng. J. Med.342, 314–319 (2000).
   PubMed Web of Science ®Google Scholar
• Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology55(Suppl. 1), S21–S31 (2000).
   PubMed Web of Science ®Google Scholar
• Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement). Neurology51, 944–948 (1998).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, Diamond MI, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache41, 646–657 (2001).
   PubMed Web of Science ®Google Scholar
• Eberhard-Gran M, Eskild A, Opjordsmoen S. Treating mood disorders during pregnancy: safety considerations. Drug Safety28(8), 695–706 (2005).
   PubMed Web of Science ®Google Scholar
• Ross EL. The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology55(Suppl. 1), S41–S46 (2000).
   PubMed Web of Science ®Google Scholar
• Devinsky O, Yerby M. Women with epilepsy. Neurol. Clin.12, 479–495 (1994).
   PubMed Web of Science ®Google Scholar
• Tatum IV WO, Liporace J, Benbadis SR, Kaplan PW. Updates on the treatment of epilepsy in women. Arch. Intern. Med.164, 137–145 (2004).
   PubMed Web of Science ®Google Scholar
• Tatum IV WO, Galvez R, Benbadis SR, Carrazana E. New antiepileptic drugs: into the new millennium. Arch. Fam. Med.9, 1135–1141 (2000).
   PubMedGoogle Scholar
• Morrell MJ, Montouris GD. Reproductive disturbances in patients with epilepsy. Cleve Clin. J. Med.7(Suppl. 2), S19–S24 (2004).
   Google Scholar
• Karnard DR, Guntupalli KK. Neurologic disorders in pregnancy. Critical Care Medicine33(Suppl. 10), S362–S371 (2005).
   PubMedGoogle Scholar
• Kaplan PW. The neurologic consequences of eclampsia. The Neurologist7(6), 357–363 (2001).
   PubMed Web of Science ®Google Scholar
• Laskowska M, Leszczynska-Gorzelak B, Oleszczuk J. Pregnancy in women with epilepsy. Gynecol. Obstet. Invest.51(2), 99–102 (2001).
   PubMed Web of Science ®Google Scholar
• Kean LH, Gargari SS, Suwanrath C, Sahota DS, James DK. A comparison of fetal behavior in term fetuses exposed to anticonvulsant medication with unexposed controls. BJOG108(11), 1159–1163 (2001).
   PubMedGoogle Scholar
• Hvas CL, Henriksen TB, Ostergaard JR, Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. BJOG107(7), 896–902 (2000).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, Lander C. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J. Clinical Neuroscience10(5), 543–549 (2003).
   PubMed Web of Science ®Google Scholar
• Vajda FJ, O’Brien TJ, Hitchcock A et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of antiepileptic drugs in pregnancy. J. Clin. Neurosci.11, 854–858 (2004).
   PubMed Web of Science ®Google Scholar
• Yerby MS. The use anticonvulsants during pregnancy. Semin. Perinatol.25(3), 153–158 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Harvey EA, Coull BA et al. The teratogenicity of anticonvulsant drugs. N. Engl. J. Med.344, 1132–1138 (2001).
   PubMed Web of Science ®Google Scholar
• Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurology4, 781–786 (2005).
   PubMed Web of Science ®Google Scholar
• Koch S, Losche G, Jager-Roman E et al. Major and minor birth malformations and antiepileptic drugs. Neurology42(Suppl. 5), 83–88 (1992).
   PubMedGoogle Scholar
• Fried S, Kozer E, Nulman E, Elinarson TR, Koren G. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Safety45, 1171–1175 (2004).
   Google Scholar
• Pennell PB. Pregnancy in women who have epilepsy. Neurol. Clin.22, 799–820 (2004).
   PubMed Web of Science ®Google Scholar
• The EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP Epilepsy Pregnancy Register. Neurology66, 354–360 (2006).
   PubMed Web of Science ®Google Scholar
• Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology61(6 Suppl. 2), S35–S42 (2003).
   PubMed Web of Science ®Google Scholar
• Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia20, 729–737 (1979).
   PubMed Web of Science ®Google Scholar
• Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA, Liverpool and Manchester Neurodevelopment Study Group. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology64, 949–954 (2005).
   PubMed Web of Science ®Google Scholar
• Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J. Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst. Rev.3, CD004848 (2004).
   PubMedGoogle Scholar
• Richmond JR, Krishnamoorthy P, Andermann E, Benjamin A. Epilepsy and pregnancy: an obstetric perspective. Am. J. Ob. Gyn.190(2), 371–379 (2004).
   PubMed Web of Science ®Google Scholar
• Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia46(Suppl. 9), 117–124 (2005).
   PubMed Web of Science ®Google Scholar
• Beghi E, Annegers JF, Collaborative Group for the Pregnancy Registries in Epilepsy. Pregnancy registries in epilepsy. Epilepsia42(11), 1142–1425 (2001).
   Google Scholar
• Morrell M. Epilepsy and pregnancy: minimizing the risks. Contemp. Ob. Gyn.49, 51–70 (2004).
   Google Scholar
• Mawer G, Clayton-Smith J, Coyle H et al. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure11, 512–518 (2002).
   PubMed Web of Science ®Google Scholar
• Canger R, Battino D, Canevini MP et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia40, 1231–1236 (1999).
   PubMed Web of Science ®Google Scholar
• Samren EB, van Duijn CM, Christiaens GCML, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann. Neurol.46(5), 739–746 (1999).
   PubMed Web of Science ®Google Scholar
• Sabers A, Dam M, a-Rogvi-Hansen B et al. Epilepsy and pregnancy: lamotrigine as main drug used. Acta. Neurol. Scand.109, 9–13 (2004).
   PubMed Web of Science ®Google Scholar
• Kaneko S, Battino D, Andermann E et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res.33, 145–158 (1999).
   PubMed Web of Science ®Google Scholar
• Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology60, 575–579 (2003).
   PubMed Web of Science ®Google Scholar
• Lowe SA. Drugs in pregnancy. Anticonvulsants and drugs for neurological disease. Best Pract. Res. Clin. Obstet. Gynaecol.15(6), 863–876 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF. North American antiepileptic drug pregnancy registry. Epilepsia45(11), 1465 (2004).
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Registry. J. Neurol. Neurosurg. Psychiatry77, 193–198 (2006).
   PubMed Web of Science ®Google Scholar
• Artama M, Auvinen A, Raudaskoski T, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology64, 1874–1878 (2005).
   PubMed Web of Science ®Google Scholar
• Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based study. Acta Pediatr.93, 174–176 (2004).
   PubMed Web of Science ®Google Scholar
• Meador KJ, Loring DW, Baker G et al, NEAD Study Group. Differential and dose dependent effects of in utero antiepileptic drugs. Neurology64(Suppl. 1), A427 (2005).
   Google Scholar
• Barrett C, Richens A. Epilepsy and pregnancy: report of an epilepsy research foundation workshop. Epilepsy Res.42, 147–187 (2003).
   Google Scholar
• Samren EB, van Duijn DM, Koch S et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia38(9), 981–990 (1997).
   PubMed Web of Science ®Google Scholar
• Dean JCS, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet.39, 251–259 (2002).
   PubMed Web of Science ®Google Scholar
• Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev. Med. Child Neurol.36(4), 361–369 (1994).
   PubMed Web of Science ®Google Scholar
• Wyszynski DF, Nambisan M, Surve T et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology64, 961–915 (2005).
   PubMed Web of Science ®Google Scholar
• Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology42(Suppl. 5), 17–24 (1992).
   PubMedGoogle Scholar
• Bennett GD, Wlodarczyk B, Calvin JA, Craig JC, Finnell RH. Valproic acid-induced alterations in growth and neurotrophic factor. Reprod. Toxicol.14, 1–11 (2000).
   PubMed Web of Science ®Google Scholar
• Duncan S, Mercho S, Lopes-Cendes I et al. Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia42(6), 750–753 (2001).
   PubMed Web of Science ®Google Scholar
• Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry70(1), 15–21 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF, Lieberman E, AED Pregnancy Registry. The AED (antiepileptic drug) Pregnancy Registry: a 6 year experience. Arch. Neurol.61, 673–678 (2004).
   PubMed Web of Science ®Google Scholar
• Reinisch JM, Sanders SA, Mortenson EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA274, 1518–1525 (1995).
   PubMed Web of Science ®Google Scholar
• Adams J, Harvey EA, Holmes LB. Cognitive deficits following gestational monotherapy with phenobarbital and carbamazepine. Neurotoxicol. Teratol.22, 466–467 (2000).
   Google Scholar
• Oguni M, Osawa M. Epilepsy and pregnancy. Epilepsia45(Suppl. 8), 37–41 (2004).
   PubMedGoogle Scholar
• Lindhout D, Omtzigt JG. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia35(Suppl. 4), S19–S28 (1994).
   PubMed Web of Science ®Google Scholar
• Gaily E, Kantola-Sorsa E, Hiilesmaa V. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology62(1), 28–32 (2004).
   PubMed Web of Science ®Google Scholar
• Cunnington M, Tennis P, International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy. Neurology64, 955–960 (2005).
   PubMed Web of Science ®Google Scholar
• Holmes LB, Wyszynski DF, Baldwin EJ, Haebecker E, Glassman LH, Smith CR. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy. Birth Defects Res. Part A Clin. Mol. Teratol.76(5), 318A (2006).
   Google Scholar
• Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR. The impact of pregnancy and childbirth on the metabolism of lamotrigine. Neurology62(2), 292–295 (2004).
   PubMed Web of Science ®Google Scholar
• de Haan GJ, Edelbroek P, Segers J et al. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study. Neurology63, 571–573 (2004).
   PubMed Web of Science ®Google Scholar
• Mazzucchelli I, Onat FY, Ozkara C et al. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia47(3), 504–509 (2006).
   PubMed Web of Science ®Google Scholar
• Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr. Med. Res. Opin.21(5), 693–701 (2005).
   PubMed Web of Science ®Google Scholar
• Meischenguiser R, D’Giano CH, Ferraro SM. Oxcarbazeine n pregnancy: clinical experience in Argentina. Epilepsy Behav.5, 163–167 (2004).
   PubMed Web of Science ®Google Scholar
• Montouris G. Gabapentin exposure in human pregnancy: results from the gabapentin pregnancy registry. Epilepsy Behav.4, 310–317 (2003).
   PubMed Web of Science ®Google Scholar
• Kuzniecky RI, Mortati K. Practical strategies for switching to newer antiepileptic drugs. Rev. Neurol. Dis.2(4), 186–198 (2005).
   PubMedGoogle Scholar
• ten Berg K. Samren EB, van Oppen AC et al. Leviteracetam use and pregnancy outcome. Reprod. Toxicol.20, 175–178 (2005).
   PubMed Web of Science ®Google Scholar
• Kondo T, Kaneko S, Amano Y, Egawa I. Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epilepsia37, 1242–1244 (1996).
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D. Teratogenicity of antiepileptic drugs: state of the art. Curr. Opin. Neurol.18, 135–140 (2005).
   PubMed Web of Science ®Google Scholar
• Pschirrer ER. Seizure disorders in pregnancy. Obstet. Gynecol. Clin. North Am.31(2), 373–384 (2004).
   PubMed Web of Science ®Google Scholar
• Jager-Roman E, Deichl A, Jakob S et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J. Pediatr.108(6), 997–1004 (1986).
   PubMed Web of Science ®Google Scholar
• Koch S, Jager-Roman E, Losche G, Nau H, Rating D, Helge H. Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome. Acta. Pediatr84, 739–746 (1996).
   Google Scholar
• Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: The Treatment of Epilepsy. Principles and Practices, 4th Edition. Wyllie E (Ed). Lippincott Williams & Wilkins, PA, USA, 1215–1226 (2005).
   Google Scholar
• Tomson T, Perucca E, Battino D. Navigating toward fetal and maternal health: the challenges of treating epilepsy in pregnancy. Epilepsia45, 1171–1175 (2004).
   PubMed Web of Science ®Google Scholar
• Williams J, Myson V, Steward SF. Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis. Epilepsia43, 824–831 (2002).
   PubMed Web of Science ®Google Scholar